
Medicines to help treat infants with cystic fibrosis along with new therapies for patients with advanced ovarian cancer will be subsidised under the Pharmaceutical Benefits Scheme.
Multiple new treatments were added to the scheme on January 1, which will see patients save tens of thousands of dollars in prescription costs.